FITBI Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations BSVN Q1 2026 Earnings EPS Surges Past Estimates by 21 Solid Biosciences Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline CRDF Q1 2026 Earnings WiderthanExpected Loss Reflects Ongoing RD Investments Sera Prognostics Q1 2026 Earnings InLine Loss and No Revenue as Stock Surges on Pipeline Progress UMBFO Q1 2026 Earnings Strong EPS Beat Reflects Solid Performance